绝经后韩国女性接受双膦酸盐治疗中非典型股骨骨折的易感因素:单中心8年经验
该回顾性巢式病例对照研究纳入至少使用双膦酸盐1年的35,104例患者,其中43例女性(平均年龄68岁)发生非典型股骨骨折(0.12%)。多因素Cox回归显示,长期使用糖皮质激素、持续暴露于双膦酸盐而未停药以及体重指数每增加1 kg/m²,分别使非典型股骨骨折的风险比增加3.0、5.2和1.2。作者认为应考虑将长期使用双膦酸盐和糖皮质激素者换用其他骨保护剂。
要点
- 在35,104例使用双膦酸盐至少1年的患者中,43例女性发生非典型股骨骨折(0.12%),平均年龄68岁。
- 非典型股骨骨折患者平均双膦酸盐暴露时间为7.3年,比无骨折者更长且持续治疗无药物假期。
- 长期使用糖皮质激素、持续双膦酸盐暴露及BMI每增加1 kg/m²分别使AFF风险比增加3.0、5.2和1.2。
核心结论
- 长期和持续使用双膦酸盐、长期使用糖皮质激素以及较高的体重指数增加非典型股骨骨折的风险。
- 作者认为应考虑将长期使用双膦酸盐和糖皮质激素的患者换用其他骨保护剂。
研究设计与样本
- 回顾性巢式病例对照研究,纳入至少使用双膦酸盐1年的患者,从手术和影像记录中识别非典型股骨骨折患者。
- 为每例非典型股骨骨折患者随机选取3例无骨折史、年龄和性别匹配的对照。
- 使用Cox比例风险模型分析危险因素对双膦酸盐相关非典型股骨骨折的独立贡献。
主要发现
- 在35,104例处方双膦酸盐至少1年的患者中,43例女性(平均年龄68岁)发生非典型股骨骨折(0.12%)。
- 非典型股骨骨折患者平均双膦酸盐暴露时间为7.3年,比无骨折患者暴露更长且持续治疗无药物假期。
- 非典型股骨骨折患者中更多患者曾使用糖皮质激素和改善病情抗风湿药。
- 多因素Cox回归估计,长期使用糖皮质激素、持续双膦酸盐暴露而未停药以及体重指数每增加1 kg/m²,分别使非典型股骨骨折的风险比增加3.0、5.2和1.2。
关键数值与推荐
- 非典型股骨骨折在至少使用双膦酸盐1年的35,104例患者中发生43例(0.12%)。
- 非典型股骨骨折患者平均双膦酸盐暴露时间为7.3年。
- 长期使用糖皮质激素使非典型股骨骨折的风险比增加3.0。
- 持续双膦酸盐暴露而未停药使非典型股骨骨折的风险比增加5.2。
- 体重指数每增加1 kg/m²使非典型股骨骨折的风险比增加1.2。
临床怎么用
- 作者认为应考虑将长期使用双膦酸盐和糖皮质激素的患者换用其他骨保护剂。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: The risk factors for atypical femur fracture in patients exposed to bisphosphonates for at least 1 year were examined. Prolonged and continuous use of bisphosphonates, long-term use of glucocorticoids, and a higher body mass index were associated with increased risk of atypical femur fracture. INTRODUCTION: The purpose of the present study is to determine whether rheumatoid arthritis (RA) and other clinical factors are associated with an increased risk of bisphosphonate (BP)-related atypical femur fracture (AFF). METHODS: A retrospective nested case-control study of patients who had taken BPs for at least 1 year was conducted. Patients with AFF were identified by reviewing surgical and radiographic records. Three controls with no history of AFFs were randomly selected and age- and sex-matched to each patient with AFFs. Cox proportional hazard models were used to analyze the independent contribution of risk factors to BP-related AFF. RESULTS: Among the 35,104 patients prescribed BPs for at least 1 year, 43 females (mean age, 68 years) suffered AFFs (0.12%). Patients with AFFs were exposed to BPs for a mean of 7.3 years. Patients with AFFs were exposed to BPs for longer than those without AFFs and continued treatment without a drug holiday. More patients with AFF than controls had taken glucocorticoids and disease-modifying anti-rheumatic drugs. Multivariate Cox regression analyses estimated that long-term use of glucocorticoids, prolonged exposure to BP without cessation, and every 1 kg/m2 increase in the body mass index (BMI) increased the hazard ratio for AFFs by 3.0, 5.2, and 1.2, respectively. CONCLUSIONS: Prolonged and continuous use of BPs, long-term use of glucocorticoids, and a higher BMI increase the risk of AFFs. Switching long-term BP and glucocorticoid users to other bone-protective agents should be considered.
引用
- Koh JH, Myong JP, Yoo J, et al. Predisposing factors associated with atypical femur fracture among postmenopausal Korean women receiving bisphosphonate therapy: 8 years' experience in a single center. Osteoporos Int. 2017. PMID: 28748389. doi:10.1007/s00198-017-4169-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。